IBDEI21T ; ; 04-FEB-2020
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,32695,1,4,0)
;;=4^H18.51
;;^UTILITY(U,$J,358.3,32695,2)
;;=^268988
;;^UTILITY(U,$J,358.3,32696,0)
;;=H16.213^^128^1667^9
;;^UTILITY(U,$J,358.3,32696,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32696,1,3,0)
;;=3^Exposure Keratoconjunctivitis,OU
;;^UTILITY(U,$J,358.3,32696,1,4,0)
;;=4^H16.213
;;^UTILITY(U,$J,358.3,32696,2)
;;=^5004922
;;^UTILITY(U,$J,358.3,32697,0)
;;=H16.211^^128^1667^7
;;^UTILITY(U,$J,358.3,32697,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32697,1,3,0)
;;=3^Exposure Keratoconjunctivitis,OD
;;^UTILITY(U,$J,358.3,32697,1,4,0)
;;=4^H16.211
;;^UTILITY(U,$J,358.3,32697,2)
;;=^5004920
;;^UTILITY(U,$J,358.3,32698,0)
;;=H16.212^^128^1667^8
;;^UTILITY(U,$J,358.3,32698,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32698,1,3,0)
;;=3^Exposure Keratoconjunctivitis,OS
;;^UTILITY(U,$J,358.3,32698,1,4,0)
;;=4^H16.212
;;^UTILITY(U,$J,358.3,32698,2)
;;=^5004921
;;^UTILITY(U,$J,358.3,32699,0)
;;=H21.81^^128^1667^70
;;^UTILITY(U,$J,358.3,32699,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32699,1,3,0)
;;=3^Floppy Iris Syndrome
;;^UTILITY(U,$J,358.3,32699,1,4,0)
;;=4^H21.81
;;^UTILITY(U,$J,358.3,32699,2)
;;=^5005263
;;^UTILITY(U,$J,358.3,32700,0)
;;=H20.812^^128^1667^59
;;^UTILITY(U,$J,358.3,32700,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32700,1,3,0)
;;=3^Fuchs' Heterochromic Cyclitis,OS
;;^UTILITY(U,$J,358.3,32700,1,4,0)
;;=4^H20.812
;;^UTILITY(U,$J,358.3,32700,2)
;;=^5005163
;;^UTILITY(U,$J,358.3,32701,0)
;;=H20.811^^128^1667^58
;;^UTILITY(U,$J,358.3,32701,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32701,1,3,0)
;;=3^Fuchs' Heterochromic Cyclitis,OD
;;^UTILITY(U,$J,358.3,32701,1,4,0)
;;=4^H20.811
;;^UTILITY(U,$J,358.3,32701,2)
;;=^5005162
;;^UTILITY(U,$J,358.3,32702,0)
;;=H18.50^^128^1667^33
;;^UTILITY(U,$J,358.3,32702,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32702,1,3,0)
;;=3^Hereditary Corneal Dystrophies,Unspec
;;^UTILITY(U,$J,358.3,32702,1,4,0)
;;=4^H18.50
;;^UTILITY(U,$J,358.3,32702,2)
;;=^5005084
;;^UTILITY(U,$J,358.3,32703,0)
;;=H21.02^^128^1667^61
;;^UTILITY(U,$J,358.3,32703,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32703,1,3,0)
;;=3^Hyphema,OS
;;^UTILITY(U,$J,358.3,32703,1,4,0)
;;=4^H21.02
;;^UTILITY(U,$J,358.3,32703,2)
;;=^5005173
;;^UTILITY(U,$J,358.3,32704,0)
;;=H21.01^^128^1667^60
;;^UTILITY(U,$J,358.3,32704,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32704,1,3,0)
;;=3^Hyphema,OD
;;^UTILITY(U,$J,358.3,32704,1,4,0)
;;=4^H21.01
;;^UTILITY(U,$J,358.3,32704,2)
;;=^5005172
;;^UTILITY(U,$J,358.3,32705,0)
;;=H20.052^^128^1667^57
;;^UTILITY(U,$J,358.3,32705,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32705,1,3,0)
;;=3^Hypopyon,OS
;;^UTILITY(U,$J,358.3,32705,1,4,0)
;;=4^H20.052
;;^UTILITY(U,$J,358.3,32705,2)
;;=^5005151
;;^UTILITY(U,$J,358.3,32706,0)
;;=H20.051^^128^1667^56
;;^UTILITY(U,$J,358.3,32706,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32706,1,3,0)
;;=3^Hypopyon,OD
;;^UTILITY(U,$J,358.3,32706,1,4,0)
;;=4^H20.051
;;^UTILITY(U,$J,358.3,32706,2)
;;=^5005150
;;^UTILITY(U,$J,358.3,32707,0)
;;=H20.00^^128^1667^55
;;^UTILITY(U,$J,358.3,32707,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32707,1,3,0)
;;=3^Iridocyclitis,Unspec Acute and Subacute
;;^UTILITY(U,$J,358.3,32707,1,4,0)
;;=4^H20.00
;;^UTILITY(U,$J,358.3,32707,2)
;;=^5005133
;;^UTILITY(U,$J,358.3,32708,0)
;;=H21.262^^128^1667^54
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI21T 3781 printed Sep 23, 2025@19:56:08 Page 2
IBDEI21T ; ; 04-FEB-2020
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,32695,1,4,0)
+2 ;;=4^H18.51
+3 ;;^UTILITY(U,$J,358.3,32695,2)
+4 ;;=^268988
+5 ;;^UTILITY(U,$J,358.3,32696,0)
+6 ;;=H16.213^^128^1667^9
+7 ;;^UTILITY(U,$J,358.3,32696,1,0)
+8 ;;=^358.31IA^4^2
+9 ;;^UTILITY(U,$J,358.3,32696,1,3,0)
+10 ;;=3^Exposure Keratoconjunctivitis,OU
+11 ;;^UTILITY(U,$J,358.3,32696,1,4,0)
+12 ;;=4^H16.213
+13 ;;^UTILITY(U,$J,358.3,32696,2)
+14 ;;=^5004922
+15 ;;^UTILITY(U,$J,358.3,32697,0)
+16 ;;=H16.211^^128^1667^7
+17 ;;^UTILITY(U,$J,358.3,32697,1,0)
+18 ;;=^358.31IA^4^2
+19 ;;^UTILITY(U,$J,358.3,32697,1,3,0)
+20 ;;=3^Exposure Keratoconjunctivitis,OD
+21 ;;^UTILITY(U,$J,358.3,32697,1,4,0)
+22 ;;=4^H16.211
+23 ;;^UTILITY(U,$J,358.3,32697,2)
+24 ;;=^5004920
+25 ;;^UTILITY(U,$J,358.3,32698,0)
+26 ;;=H16.212^^128^1667^8
+27 ;;^UTILITY(U,$J,358.3,32698,1,0)
+28 ;;=^358.31IA^4^2
+29 ;;^UTILITY(U,$J,358.3,32698,1,3,0)
+30 ;;=3^Exposure Keratoconjunctivitis,OS
+31 ;;^UTILITY(U,$J,358.3,32698,1,4,0)
+32 ;;=4^H16.212
+33 ;;^UTILITY(U,$J,358.3,32698,2)
+34 ;;=^5004921
+35 ;;^UTILITY(U,$J,358.3,32699,0)
+36 ;;=H21.81^^128^1667^70
+37 ;;^UTILITY(U,$J,358.3,32699,1,0)
+38 ;;=^358.31IA^4^2
+39 ;;^UTILITY(U,$J,358.3,32699,1,3,0)
+40 ;;=3^Floppy Iris Syndrome
+41 ;;^UTILITY(U,$J,358.3,32699,1,4,0)
+42 ;;=4^H21.81
+43 ;;^UTILITY(U,$J,358.3,32699,2)
+44 ;;=^5005263
+45 ;;^UTILITY(U,$J,358.3,32700,0)
+46 ;;=H20.812^^128^1667^59
+47 ;;^UTILITY(U,$J,358.3,32700,1,0)
+48 ;;=^358.31IA^4^2
+49 ;;^UTILITY(U,$J,358.3,32700,1,3,0)
+50 ;;=3^Fuchs' Heterochromic Cyclitis,OS
+51 ;;^UTILITY(U,$J,358.3,32700,1,4,0)
+52 ;;=4^H20.812
+53 ;;^UTILITY(U,$J,358.3,32700,2)
+54 ;;=^5005163
+55 ;;^UTILITY(U,$J,358.3,32701,0)
+56 ;;=H20.811^^128^1667^58
+57 ;;^UTILITY(U,$J,358.3,32701,1,0)
+58 ;;=^358.31IA^4^2
+59 ;;^UTILITY(U,$J,358.3,32701,1,3,0)
+60 ;;=3^Fuchs' Heterochromic Cyclitis,OD
+61 ;;^UTILITY(U,$J,358.3,32701,1,4,0)
+62 ;;=4^H20.811
+63 ;;^UTILITY(U,$J,358.3,32701,2)
+64 ;;=^5005162
+65 ;;^UTILITY(U,$J,358.3,32702,0)
+66 ;;=H18.50^^128^1667^33
+67 ;;^UTILITY(U,$J,358.3,32702,1,0)
+68 ;;=^358.31IA^4^2
+69 ;;^UTILITY(U,$J,358.3,32702,1,3,0)
+70 ;;=3^Hereditary Corneal Dystrophies,Unspec
+71 ;;^UTILITY(U,$J,358.3,32702,1,4,0)
+72 ;;=4^H18.50
+73 ;;^UTILITY(U,$J,358.3,32702,2)
+74 ;;=^5005084
+75 ;;^UTILITY(U,$J,358.3,32703,0)
+76 ;;=H21.02^^128^1667^61
+77 ;;^UTILITY(U,$J,358.3,32703,1,0)
+78 ;;=^358.31IA^4^2
+79 ;;^UTILITY(U,$J,358.3,32703,1,3,0)
+80 ;;=3^Hyphema,OS
+81 ;;^UTILITY(U,$J,358.3,32703,1,4,0)
+82 ;;=4^H21.02
+83 ;;^UTILITY(U,$J,358.3,32703,2)
+84 ;;=^5005173
+85 ;;^UTILITY(U,$J,358.3,32704,0)
+86 ;;=H21.01^^128^1667^60
+87 ;;^UTILITY(U,$J,358.3,32704,1,0)
+88 ;;=^358.31IA^4^2
+89 ;;^UTILITY(U,$J,358.3,32704,1,3,0)
+90 ;;=3^Hyphema,OD
+91 ;;^UTILITY(U,$J,358.3,32704,1,4,0)
+92 ;;=4^H21.01
+93 ;;^UTILITY(U,$J,358.3,32704,2)
+94 ;;=^5005172
+95 ;;^UTILITY(U,$J,358.3,32705,0)
+96 ;;=H20.052^^128^1667^57
+97 ;;^UTILITY(U,$J,358.3,32705,1,0)
+98 ;;=^358.31IA^4^2
+99 ;;^UTILITY(U,$J,358.3,32705,1,3,0)
+100 ;;=3^Hypopyon,OS
+101 ;;^UTILITY(U,$J,358.3,32705,1,4,0)
+102 ;;=4^H20.052
+103 ;;^UTILITY(U,$J,358.3,32705,2)
+104 ;;=^5005151
+105 ;;^UTILITY(U,$J,358.3,32706,0)
+106 ;;=H20.051^^128^1667^56
+107 ;;^UTILITY(U,$J,358.3,32706,1,0)
+108 ;;=^358.31IA^4^2
+109 ;;^UTILITY(U,$J,358.3,32706,1,3,0)
+110 ;;=3^Hypopyon,OD
+111 ;;^UTILITY(U,$J,358.3,32706,1,4,0)
+112 ;;=4^H20.051
+113 ;;^UTILITY(U,$J,358.3,32706,2)
+114 ;;=^5005150
+115 ;;^UTILITY(U,$J,358.3,32707,0)
+116 ;;=H20.00^^128^1667^55
+117 ;;^UTILITY(U,$J,358.3,32707,1,0)
+118 ;;=^358.31IA^4^2
+119 ;;^UTILITY(U,$J,358.3,32707,1,3,0)
+120 ;;=3^Iridocyclitis,Unspec Acute and Subacute
+121 ;;^UTILITY(U,$J,358.3,32707,1,4,0)
+122 ;;=4^H20.00
+123 ;;^UTILITY(U,$J,358.3,32707,2)
+124 ;;=^5005133
+125 ;;^UTILITY(U,$J,358.3,32708,0)
+126 ;;=H21.262^^128^1667^54
